EARLY BRAIN INJURY OR CEREBRAL VASOSPASM, VOL 2: CLINICAL MANAGEMENT, cilt.110, ss.23-28, 2011 (SCI-Expanded)
Background: Nimodipine is the most widely preferred and administered calcium channel blocker in cerebral vasospasm prevention and treatment. There is no experimental or clinical study investigating the comparative effects of routine treatment modalities.